Angiosarcoma is a rare, aggressive soft tissue sarcoma characterized by poor prognosis and limited treatment consensus.
Our aim was to clarify the clinicopathological features, treatment outcomes, and prognostic factors of these patients to inform improved management and follow-up strategies.
